Overview

Post-Operative Treatment With Ketorolac After Abdominal Myomectomy

Status:
Completed
Trial end date:
2001-08-01
Target enrollment:
0
Participant gender:
Female
Summary
The purpose of this study is to determine if ketorolac, given after abdominal myomectomy, will decrease the frequency of post-oerative fevers as well as improve post-operative pain management.
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Ascher-Walsh, Charles, M.D.
Collaborators:
Icahn School of Medicine at Mount Sinai
New York Presbyterian Hospital
Treatments:
Ketorolac
Ketorolac Tromethamine
Criteria
Inclusion Criteria:

- Ant patient undregoing abdominal myomectomy

Exclusion Criteria:

- Patients with contraindication to NSAIDs including history of peptic ulcer disease,
renal disease, bleeding diathesis, or hypersensitivity to NSAIDS